Core Insights - Precipio, Inc. has amended its warrant exercise agreement with its largest warrant holder, changing the structure from cash exercise to a combination of cash and cashless exercise, resulting in a cash inflow of approximately $1.2 million instead of $3.8 million [1][6] Company Overview - Precipio is a healthcare biotechnology company focused on cancer diagnostics, aiming to reduce cancer misdiagnoses through innovative diagnostic products and services that enhance accuracy and improve patient outcomes [3] Financial Impact - The amendment to the warrant exercise will reduce the number of shares added to the company's outstanding shares from approximately 300,000 to between 130,000 and 150,000, depending on the share price at the time of exercise [6]

VANCOUVER, BC, July 9, 2025 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) reminds holders of its TSX-listed warrants trading under the symbol ARIS.WT.A (the Warrants) that the Warrants will automatically expire at the close of markets on July 29, 2025. Any Warrants not exercised by that time will become void and have no value.The Warrants are currently "in-the-money", with an effective exercise price of C$5.50 per share1 compared to a closing share price of C ...

SURPRISE, Ariz., July 1, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a leader in fertility control for managing animal pest populations, announced today the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on March 11, 2025, at the existing exercise price of $2.90 per share. The closing of the warrant exercise transactio ...

LUXEMBOURG, June 03, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the effects of the recent consolidation of its shares of common stock (also known as a reverse stock split) at a ratio of 1-for-8 (the “Share Consolidation”) on its publicly traded warrants. As previously disclosed, the Share Consolidation became effective as of 12:01 a.m. CET on ...

CHEYENNE, Wyo., May 9, 2025 /PRNewswire/ -- U.S. Gold Corp. ("U.S. Gold," the "Company," "we," "our" or "us") (Nasdaq: USAU) is pleased to provide an update regarding the exercises of previously issued warrants subsequent to the Company's latest Form 10-Q filing for the three months ended January 31, 2025, filed on March 17, 2025.At January 31, 2025, the Company reported 4,788,112 warrants outstanding. Since then, the Company has benefited from the exercise of 1,864,668 warrants, generating gross proceeds f ...

Reference is made to the announcement by IDEX Biometrics ASA (the "Company") on 12 December 2024 regarding the listing of Warrants A and Warrants B on Oslo Stock Exchange. Warrants B were exercisable between 31 March 2025 and 11 April 2025, and all Warrants B not exercised within such time lapsed without compensation to the holder. A total of 36,767 Warrants B were exercised, resulting in an aggregate subscription for 36,767 new shares (the "New Shares") in the Company, each Warrant B having an exercise pri ...

Vast Resources plc / Ticker: VAST / Index: AIM / Sector: Mining 29 April 2025 (“Vast” or the “Company”) Exercise of Warrants Vast Resources plc, the AIM quoted mining company, announces that it has received notice to exercise warrants over a total of 195,000,000 new ordinary shares of 0.1 pence each in the Company ("Warrant Shares") at an exercise price of 0.4p per Warrant Share, raising £780,000 for the Company. Application has been made to the London Stock Exchange for 195,000,000 new Ordinary Shares to b ...